Evidence map›Paper›PMID 25321409›Full record

ArticleNature protocols2014

Illumina human exome genotyping array clustering and quality control.

Yan Guo, Jing He, Shilin Zhao, Hui Wu, Xue Zhong, Quanhu Sheng, David C Samuels, Yu Shyr, Jirong Long

Open access · greenAbstract read
In one paragraph

Article in Nature protocols, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 4 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 4 syntheses or guidelines pooled it, 194 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Copy Number Variant Duplications Associated with Essential Tremor.Tremor and other hyperkinetic movements (New York, N.Y.) · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yan GuoCenter for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee, USA.ORCID 0000000152523960
Jing HeVanderbilt Epidemiology Center, Vanderbilt University, Nashville, Tennessee, USA.
Shilin ZhaoCenter for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee, USA.
Hui WuCenter for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee, USA.
Xue ZhongCenter for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee, USA.
Quanhu ShengCenter for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee, USA.ORCID 0000000189519295
David C SamuelsCenter for Human Genetics Research, Vanderbilt University, Nashville, Tennessee, USA.
Yu ShyrCenter for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee, USA.
Jirong LongVanderbilt Epidemiology Center, Vanderbilt University, Nashville, Tennessee, USA.
Vanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
TrainingU54CA163072 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Karen Marie Winkfield · 2011 to 2026
$20.1M
Translational Pathology CoreU54CA163069 · NCI · MEHARRY MEDICAL COLLEGE · PI BALLARD, BILLY RAY · 2011 to 2025
$18.8M
TRAININGU54CA163066 · NCI · TENNESSEE STATE UNIVERSITY · PI MARGARET M WHALEN · 2011 to 2026
$12.8M
Genome Sequencing to identify novel genetic factors for breast cancer riskR01CA158473 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2012 to 2016
$4.3M
Barrett's Esophagus Translational Research Network Coordinating CenterU01CA163056 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHYR, YU · 2011 to 2016
$2.2M
NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA158473NCI NIH HHS R01CA158473NCI NIH HHS U01 CA163056NCI NIH HHS U54 CA163066NCI NIH HHS U54 CA163069NCI NIH HHS U54 CA163072
6 · The paper itself

Abstract

With the rise of high-throughput sequencing technology, traditional genotyping arrays are gradually being replaced by sequencing technology. Against this trend, Illumina has introduced an exome genotyping array that provides an alternative approach to sequencing, especially suited to large-scale genome-wide association studies (GWASs). The exome genotyping array targets the exome plus rare single-nucleotide polymorphisms (SNPs), a feature that makes it substantially more challenging to process than previous genotyping arrays that targeted common SNPs. Researchers have struggled to generate a reliable protocol for processing exome genotyping array data. The Vanderbilt Epidemiology Center, in cooperation with Vanderbilt Technologies for Advanced Genomics Analysis and Research Design (VANGARD), has developed a thorough exome chip-processing protocol. The protocol was developed during the processing of several large exome genotyping array-based studies, which included over 60,000 participants combined. The protocol described herein contains detailed clustering techniques and robust quality control procedures, and it can benefit future exome genotyping array-based GWASs.

Indexed as

Cluster AnalysisExomeGenome, HumanQuality ControlSoftwareHumansOligonucleotide Array Sequence AnalysisPolymorphism, Single Nucleotide

Identifiers

PMID25321409
PMCPMC4441213
OpenAlexW2053250360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.